Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Rivaroxaban in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
Brief Summary: To evaluate the safety for the combination of Rivaroxaban and Ticagrel versus triple antithrombotic regimen (Vitamin K Antagonist (VKA), Clopigogrel and Aspirin) in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention (PCI).


Options:
A: Arm Label: 1. YM150 Dose V, twice daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 2. YM150 Dose W, once daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 3. YM150 Dose X, twice daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 4. YM150 Dose Y, once daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 5. YM150 Dose Y, twice daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 6. YM150 Dose Z, once daily; Type: EXPERIMENTAL; Interventions: Drug: YM150 | Arm Label: 7. Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: YM150; Assigned to Arm(s): 1. YM150 Dose V, twice daily, 2. YM150 Dose W, once daily, 3. YM150 Dose X, twice daily, 4. YM150 Dose Y, once daily, 5. YM150 Dose Y, twice daily, 6. YM150 Dose Z, once daily | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): 7. Placebo
B: Arm Label: rivaroxaban 2.5 mg twice daily; Type: EXPERIMENTAL; Interventions: Drug: rivaroxaban 2.5 mg, Drug: rivaroxaban 15 mg, Drug: rivaroxaban 10 mg, Drug: aspirin (ASA), Drug: clopidogrel, Drug: prasugrel, Drug: ticagrelor | Arm Label: vitamin K antagonist (VKA); Type: EXPERIMENTAL; Interventions: Drug: aspirin (ASA), Drug: vitamin K antagonist (VKA), Drug: clopidogrel, Drug: prasugrel, Drug: ticagrelor | Arm Label: rivaroxaban 15 mg once daily; Type: EXPERIMENTAL; Interventions: Drug: rivaroxaban 15 mg, Drug: rivaroxaban 10 mg, Drug: clopidogrel, Drug: prasugrel, Drug: ticagrelor | Intervention Type: DRUG; Name: rivaroxaban 2.5 mg; Assigned to Arm(s): rivaroxaban 2.5 mg twice daily | Intervention Type: DRUG; Name: rivaroxaban 15 mg; Assigned to Arm(s): rivaroxaban 15 mg once daily, rivaroxaban 2.5 mg twice daily | Intervention Type: DRUG; Name: rivaroxaban 10 mg; Assigned to Arm(s): rivaroxaban 15 mg once daily, rivaroxaban 2.5 mg twice daily | Intervention Type: DRUG; Name: aspirin (ASA); Assigned to Arm(s): rivaroxaban 2.5 mg twice daily, vitamin K antagonist (VKA) | Intervention Type: DRUG; Name: vitamin K antagonist (VKA); Assigned to Arm(s): vitamin K antagonist (VKA) | Intervention Type: DRUG; Name: clopidogrel; Assigned to Arm(s): rivaroxaban 15 mg once daily, rivaroxaban 2.5 mg twice daily, vitamin K antagonist (VKA) | Intervention Type: DRUG; Name: prasugrel; Assigned to Arm(s): rivaroxaban 15 mg once daily, rivaroxaban 2.5 mg twice daily, vitamin K antagonist (VKA) | Intervention Type: DRUG; Name: ticagrelor; Assigned to Arm(s): rivaroxaban 15 mg once daily, rivaroxaban 2.5 mg twice daily, vitamin K antagonist (VKA)
C: Arm Label: Dual antithrombotic therapy (DAT); Type: EXPERIMENTAL; Interventions: Drug: rivaroxaban and ticagrel therapy | Arm Label: Triple antithrombotic therapy (TAT); Type: ACTIVE_COMPARATOR; Interventions: Drug: triple antithrombotic regimen with warfarin, asipirin and clopidogrel | Intervention Type: DRUG; Name: rivaroxaban and ticagrel therapy; Assigned to Arm(s): Dual antithrombotic therapy (DAT) | Intervention Type: DRUG; Name: triple antithrombotic regimen with warfarin, asipirin and clopidogrel; Assigned to Arm(s): Triple antithrombotic therapy (TAT)
D: Arm Label: BioFreedom™ Drug Coated Stent (DCS); Type: EXPERIMENTAL; Interventions: Device: Biofreedom™ Drug Coated Stent (DCS) | Arm Label: Gazelle™ Bare Metal Coronary Stent (BMS); Type: ACTIVE_COMPARATOR; Interventions: Device: Gazelle™ Bare Metal Coronary Stent (BMS) | Intervention Type: DEVICE; Name: Biofreedom™ Drug Coated Stent (DCS); Assigned to Arm(s): BioFreedom™ Drug Coated Stent (DCS) | Intervention Type: DEVICE; Name: Gazelle™ Bare Metal Coronary Stent (BMS); Assigned to Arm(s): Gazelle™ Bare Metal Coronary Stent (BMS)

Answer: C